Methylprednisolone in adults hospitalized with COVID-19 pneumoniaAn open-label randomized trial (GLUCOCOVID)

被引：0

作者：

Luis Corral-Gudino

Alberto Bahamonde

Francisco Arnaiz-Revillas

Julia Gómez-Barquero

Jesica Abadía-Otero

Carmen García-Ibarbia

Víctor Mora

Ana Cerezo-Hernández

José L. Hernández

Graciela López-Muñíz

Fernando Hernández-Blanco

Jose M. Cifrián

Jose M. Olmos

Miguel Carrascosa

Luis Nieto

María Carmen Fariñas

José A. Riancho

机构：

[1] Universidad de Valladolid,Hospital Rio Hortega, Servicio de Medicina Interna

[2] Hospital Bierzo,Servicio de Medicina Interna

[3] Universidad de Cantabria,IDIVAL, Hospital U M Valdecilla, Servicio de Enfermedades Infecciosas

[4] Universidad de Valladolid,Hospital Rio Hortega, Servicio de Medicina Interna, Consulta de Enfermedades Infecciosas

[5] Universidad de Cantabria,IDIVAL, Hospital U M Valdecilla, Servicio de Medicina Interna

[6] Universidad de Cantabria,IDIVAL, Hospital U M Valdecilla, Servicio de Neumología

[7] Hospital Universitario Río Hortega,Servicio de Neumología

[8] Hospital Laredo,Servicio de Medicina Interna

[9] Hospital Sierrallana,Servicio de Medicina Interna

来源：

Wiener klinische Wochenschrift | 2021年 / 133卷

关键词：

Glucocorticoids; SARS-CoV-2; Mortality; Coronavirus Infections; Humans;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：303 / 311

页数：8

共 50 条

[1] Methylprednisolone in adults hospitalized with COVID-19 pneumonia An open-label randomized trial (GLUCOCOVID)
Corral-Gudino, Luis
Bahamonde, Alberto
Arnaiz-Revillas, Francisco
Gomez-Barquero, Julia
Abadia-Otero, Jesica
Garcia-Ibarbia, Carmen
Mora, Victor
Cerezo-Hernandez, Ana
Hernandez, Jose L.
Lopez-Muniz, Graciela
Hernandez-Blanco, Fernando
Cifrian, Jose M.
Olmos, Jose M.
Carrascosa, Miguel
Nieto, Luis
Farinas, Maria Carmen
Riancho, Jose A.
WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (7-8) : 303 - 311
[2] Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Philippe Bégin
Jeannie Callum
Erin Jamula
Richard Cook
Nancy M. Heddle
Alan Tinmouth
Michelle P. Zeller
Guillaume Beaudoin-Bussières
Luiz Amorim
Renée Bazin
Kent Cadogan Loftsgard
Richard Carl
Michaël Chassé
Melissa M. Cushing
Nick Daneman
Dana V. Devine
Jeannot Dumaresq
Dean A. Fergusson
Caroline Gabe
Marshall J. Glesby
Na Li
Yang Liu
Allison McGeer
Nancy Robitaille
Bruce S. Sachais
Damon C. Scales
Lisa Schwartz
Nadine Shehata
Alexis F. Turgeon
Heidi Wood
Ryan Zarychanski
Andrés Finzi
Donald M. Arnold
Nature Medicine, 2021, 27 : 2012 - 2024
[3] Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Begin, Philippe
Callum, Jeannie
Jamula, Erin
Cook, Richard
Heddle, Nancy M.
Tinmouth, Alan
Zeller, Michelle P.
Beaudoin-Bussieres, Guillaume
Amorim, Luiz
Bazin, Renee
Loftsgard, Kent Cadogan
Carl, Richard
Chasse, Michael
Cushing, Melissa M.
Daneman, Nick
Devine, Dana, V
Dumaresq, Jeannot
Fergusson, Dean A.
Gabe, Caroline
Glesby, Marshall J.
Li, Na
Liu, Yang
McGeer, Allison
Robitaille, Nancy
Sachais, Bruce S.
Scales, Damon C.
Schwartz, Lisa
Shehata, Nadine
Turgeon, Alexis F.
Wood, Heidi
Zarychanski, Ryan
Finzi, Andres
Arnold, Donald M.
NATURE MEDICINE, 2021, 27 (11) : 2012 - +
[4] Ribavirin aerosol in hospitalized adults with respiratory distress and COVID-19: An open-label trial
Poulakou, Garyfallia
Barakat, Maxime
Israel, Robert J.
Bacci, Marcelo R.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (01): : 165 - 174
[5] NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial
Gerain, Jean
Uebelhoer, Melanie
Costes, Berenice
Herman, Julie
Pietri, Sandra
Donneau, Anne-Francoise
Monseur, Justine
Henrotin, Yves
FRONTIERS IN NUTRITION, 2023, 10
[6] A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia
Avendano-Sola, Cristina
Ramos-Martinez, Antonio
Munez-Rubio, Elena
Ruiz-Antoran, Belen
Malo de Molina, Rosa
Torres, Ferran
Fernandez-Cruz, Ana
Calderon-Parra, Jorge
Payares-Herrera, Concepcion
Diaz de Santiago, Alberto
Romera-Martinez, Irene
Pintos, Ilduara
Lora-Tamayo, Jaime
Mancheno-Losa, Mikel
Paciello, Maria L.
Martinez-Gonzalez, A. L.
Vidan-Estevez, Julia
Nunez-Orantos, Maria J.
Isabel Saez-Serrano, Maria
Porras-Leal, Maria L.
Jarilla-Fernandez, Maria C.
Villares, Paula
Perez de Oteyza, Jaime
Ramos-Garrido, Ascension
Blanco, Lydia
Madrigal-Sanchez, Maria E.
Rubio-Batlles, Martin
Velasco-Iglesias, Ana
Pano-Pardo, Jose R.
Moreno-Chulilla, J. A.
Muniz-Diaz, Eduardo
Casas-Flecha, Inmaculada
Perez-Olmeda, Mayte
Garcia-Perez, Javier
Alcami, Jose
Bueno, Jose L.
Duarte, Rafael F.
JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (20):
[7] Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Philippe Bégin
Jeannie Callum
Erin Jamula
Richard Cook
Nancy M. Heddle
Alan Tinmouth
Michelle P. Zeller
Guillaume Beaudoin-Bussières
Luiz Amorim
Renée Bazin
Kent Cadogan Loftsgard
Richard Carl
Michaël Chassé
Melissa M. Cushing
Nick Daneman
Dana V. Devine
Jeannot Dumaresq
Dean A. Fergusson
Caroline Gabe
Marshall J. Glesby
Na Li
Yang Liu
Allison McGeer
Nancy Robitaille
Bruce S. Sachais
Damon C. Scales
Lisa Schwartz
Nadine Shehata
Alexis F. Turgeon
Heidi Wood
Ryan Zarychanski
Andrés Finzi
Donald M. Arnold
Nature Medicine, 2022, 28 : 212 - 212
[8] A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19
Doi, Yohei
Hibino, Masaya
Hase, Ryota
Yamamoto, Michiko
Kasamatsu, Yu
Hirose, Masahiro
Mutoh, Yoshikazu
Homma, Yoshito
Terada, Masaki
Ogawa, Taku
Kashizaki, Fumihiro
Yokoyama, Toshihiko
Koba, Hayato
Kasahara, Hideki
Yokota, Kazuhisa
Kato, Hideaki
Yoshida, Junichi
Kita, Toshiyuki
Kato, Yasuyuki
Kamio, Tadashi
Kodama, Nobuhiro
Uchida, Yujiro
Ikeda, Nobuhiro
Shinoda, Masahiro
Nakagawa, Atsushi
Nakatsumi, Hiroki
Horiguchi, Tomoya
Iwata, Mitsunaga
Matsuyama, Akifumi
Banno, Sumi
Koseki, Takenao
Teramachi, Mayumi
Miyata, Masami
Tajima, Shigeru
Maeki, Takahiro
Nakayama, Eri
Taniguchi, Satoshi
Lim, Chang Kweng
Saijo, Masayuki
Imai, Takumi
Yoshida, Hisako
Kabata, Daijiro
Shintani, Ayumi
Yuzawa, Yukio
Kondo, Masashi
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (12)
[9] Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial
Rahhal, Alaa
Najim, Mostafa
Aljundi, Amer Hussein
Mahfouz, Ahmed
Alyafei, Sumaya Mehdar
Awaisu, Ahmed
Habib, Mhd Baraa
Obeidat, Ibrahim
Faisal, Mohanad Mohammed
Alanzi, Meshaal Ali
Nair, Arun Prabhakaran
Elhassan, Areeg
Al-Dushain, Abdullah
Abdelmajid, Alaaeldin Abdelmajid
Abdelgader, Ahmed Elfadil
Moursi, Ahmed Mahmoud Ahmed
Alharafsheh, Ahmad Eid Nazzal
Abou Kamar, Mohd Ragheb
Goravey, Wael
Omar, Amr Salah
Abukhattab, Mohammed
Khatib, Mohamad Yahya
Mohamedali, Mohamed Gaafar
AlMaslamani, Muna A. Rahman
Alemadi, Samar
MEDICINE, 2022, 101 (39) : E30618
[10] METHYLENE BLUE FOR TREATMENT OF HOSPITALIZED COVID-19 PATIENTS: A RANDOMIZED, CONTROLLED, OPEN-LABEL CLINICAL TRIAL, PHASE 2
Hamidi-Alamdari, Daryoush
Hafizi-Lotfabadi, Saied
Bagheri-Moghaddam, Ahmad
Safari, Hossin
Mozdourian, Mahnaz
Javidarabshahi, Zahra
Peivandi-Yazdi, Arash
Ali-Zeraati, Abass
Sedaghat, Alireza
Poursadegh, Farid
Barazandeh-Ahmadabadi, Fatemeh
Agheli-Rad, Marzieh
Tavousi, Seyed M.
Vojouhi, Shohreh
Amini, Shahram
Amini, Mahnaz
Majid-Hosseini, Seyed
Tavanaee-Sani, Ashraf
Ghiabi, Amin
Nabavi-Mahalli, Shima
Morovatdar, Negar
Rajabi, Omid
Koliakos, George
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2021, 73 (03): : 190 - 198

← 1 2 3 4 5 →